Terms: = Skin cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
822 results:
1. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
2. Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
3. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract] [Full Text] [Related]
4. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
5. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/akt signaling pathway.
Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA circFCHO2(hsa_circ_0002490) promotes the proliferation of melanoma by directly binding to DND1.
Yang Y; Li J; Wei C; Wang L; Gao Z; Shen K; Li Y; Ren M; Zhu Y; Ding Y; Wei C; Zhang T; Zheng S; Lu N; Gu J
Cell Biol Toxicol; 2024 Feb; 40(1):9. PubMed ID: 38311675
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
8. ATF5 promotes malignant T cell survival through the PI3K/akt/mTOR pathway in cutaneous T cell lymphoma.
Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
[TBL] [Abstract] [Full Text] [Related]
9. Loureirin A Promotes Cell Differentiation and Suppresses Migration and Invasion of Melanoma Cells via WNT and akt/mTOR Signaling Pathways.
Xia ZY; Liu L; Kuok CF; Wang XL; Shi D; Ma Q; Cheng XY; Wang GL; Li MJ; Zheng QS; Liu XN; Li DF; Li BH
Biol Pharm Bull; 2024 Feb; 47(2):486-498. PubMed ID: 38199251
[TBL] [Abstract] [Full Text] [Related]
10. PTEN-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells.
Wang S; Riedstra CP; Zhang Y; Anandh S; Dudley AC
Br J Cancer; 2024 Mar; 130(4):555-567. PubMed ID: 38148377
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors.
Kovacs D; Flori E; Bastonini E; Mosca S; Migliano E; Cota C; Zaccarini M; Briganti S; Cardinali G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139209
[TBL] [Abstract] [Full Text] [Related]
12. β-endorphin suppresses ultraviolet B irradiation-induced epidermal barrier damage by regulating inflammation-dependent mTORC1 signaling.
Kim HS; Kim HJ; Hong YD; Son ED; Cho SY
Sci Rep; 2023 Dec; 13(1):22357. PubMed ID: 38102220
[TBL] [Abstract] [Full Text] [Related]
13. A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.
Dunsche L; Ivanisenko N; Riemann S; Schindler S; Beissert S; Angeli C; Kreis S; Tavassoli M; Lavrik I; Kulms D
Cell Death Dis; 2023 Dec; 14(12):831. PubMed ID: 38097548
[TBL] [Abstract] [Full Text] [Related]
14. Paris polyphylla saponins II inhibits invasive, migration and epithelial-mesenchymal transition of melanoma cells through activation of autophagy.
Cheng H; Chu J; Yang Y; Li Y; Wang M; Wu H; Wang M; Su J; Li Q
Toxicon; 2024 Jan; 237():107558. PubMed ID: 38072315
[TBL] [Abstract] [Full Text] [Related]
15. Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro.
Yan C; Zhao L; Zhang X; Chu Z; Zhou T; Zhang Y; Geng S; Guo K
J Biophotonics; 2024 Mar; 17(3):e202300356. PubMed ID: 38041219
[TBL] [Abstract] [Full Text] [Related]
16. Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities.
Deng YQ; Gao M; Lu D; Liu QP; Zhang RJ; Ye J; Zhao J; Feng ZH; Li QZ; Zhang H
Phytomedicine; 2024 Jan; 123():155169. PubMed ID: 37992493
[TBL] [Abstract] [Full Text] [Related]
17. MiR126-targeted-nanoparticles combined with PI3K/akt inhibitor as a new strategy to overcome melanoma resistance.
Arasi MB; De Luca G; Chronopoulou L; Pedini F; Petrucci E; Flego M; Stringaro A; Colone M; Pasquini L; Spada M; Lulli V; Perrotta MC; Calin GA; Palocci C; Biffoni M; Felicetti F; Felli N
Mol Ther; 2024 Jan; 32(1):152-167. PubMed ID: 37990493
[TBL] [Abstract] [Full Text] [Related]
18. Preparation of
Qi J; Qi X; Chen H; Rui W
Anticancer Agents Med Chem; 2024; 24(2):132-145. PubMed ID: 37957869
[TBL] [Abstract] [Full Text] [Related]
19. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
[Next]
